DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.72 +0.09 (+1.04%)
At close: Oct 23, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Sale and Maturity of Investments (2019 - 2026)

Updated

Analysis

DiaMedica Therapeutics (DMAC) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 DiaMedica Therapeutics 470.23 Mn 260.19 Mn - 13.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.00 Mn
Mar 31, 2026 16.79 Mn
Dec 31, 2025 16.06 Mn
Sep 30, 2025 9.10 Mn
Jun 30, 2025 18.47 Mn
Mar 31, 2025 13.50 Mn
Dec 31, 2024 16.00 Mn
Sep 30, 2024 16.00 Mn
Jun 30, 2024 13.00 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 11.00 Mn
Sep 30, 2023 13.00 Mn
Jun 30, 2023 14.80 Mn
Mar 31, 2023 12.34 Mn
Dec 31, 2022 14.55 Mn
Sep 30, 2022 10.50 Mn
Jun 30, 2022 16.67 Mn
Mar 31, 2022 15.59 Mn
Dec 31, 2021 13.39 Mn
Sep 30, 2021 9.67 Mn
API Access

DiaMedica Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=DMAC&period=max&api_key=YOUR_API_KEY